News Detail
Date/Time
28 Sep 2017 22:33:00
Headline
Information Memorandum on the Asset Acquisition of NUSA and Disposal of Assets of a Subsidiary. (Additional)
Symbol
NUSA
Source
NUSA
Acquisition and disposition of assets Ref. NUSA. 051/2017 Date: May 29, 2017 Subject: Resolution of the Board of Directors Meeting No. 5/2017 Information Memorandum on the Asset Acquisition of NUSA and Disposal of Assets of a Subsidiary. (Additional) Attention : Director and Manager The Stock Exchange of Thailand Refers to the Board of Directors of Nusasiri Public Company Limited ("the company" or "NUSA") Meeting No. 5/2017 held on May 29, 2017, the meeting had approved to the transaction, the acquisition and disposition of assets following; 1. The meeting approved the investment in the company Panacee Medical Hong Kong Limited, running a Wellness Business in Hong Kong and China, total registered capital of 80,000,000 HKD. 2. The Meeting resolved to approve the transactions and disposition of assets of the subsidiary "Nusa Sriracha Condotel Company Limited" the sale of investment in subsidiaries 50% of the share capital, a value of Baht 175 million for the Sangfah Construction & Engineering Company Limited the large construction companies in the country experience in the construction of large buildings, the intention to participate in the project invested assets Sriracha Phase 1. (More details as attached) ______________________________________________________________________ This announcement was prepared and disseminated by listed company or issuer through the electronic system which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement.